<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>ERN-GENTURIS guideline summary: Surveillance protocol in carriers of germline disease-causing &lt;EM&gt;TP53&lt;/EM&gt; variants</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">ERN-GENTURIS guideline summary: Surveillance protocol in carriers of germline disease-causing <em>TP53</em> variants</h1>
<div class="graphic"><div class="figure"><div class="ttl">ERN-GENTURIS guideline summary: Surveillance protocol in carriers of germline disease-causing <em>TP53</em> variants</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup span="3" width="15%"></colgroup><colgroup width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Exam</td> <td class="subtitle1">Periodicity</td> <td class="subtitle1">Age to start</td> <td class="subtitle1">Age to end</td> <td class="subtitle1">Select clinical indications</td> </tr> <tr> <td class="divider_bottom" rowspan="2">Clinical examination with, in children, specific attention to signs of virilization or early puberty and measurement of blood pressure and, in patients who received radiotherapy, to occurrence of basal cell carcinomas within the radiotherapy field</td> <td>Every 6 months</td> <td>Birth</td> <td>17 years</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Annual</td> <td>18 years</td> <td>Indefinite</td> <td> </td> </tr> <tr> <td class="divider_bottom" rowspan="2">Whole-body MRI without gadolinium enhancement</td> <td class="divider_bottom" rowspan="2">Annual</td> <td>Birth</td> <td>Indefinite</td> <td>High cancer risk <em>TP53</em> variant* or patient previously treated by chemotherapy or radiotherapy</td> </tr> <tr class="divider_bottom"> <td>18 years</td> <td>Indefinite</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Breast MRI</td> <td>Annual</td> <td>20 years</td> <td>65 years</td> <td> </td> </tr> <tr> <td class="divider_bottom" rowspan="2">Brain MRI<sup>¶</sup></td> <td class="divider_bottom" rowspan="2">Annual</td> <td>Birth</td> <td>18 years</td> <td>High cancer risk <em>TP53</em> variant</td> </tr> <tr class="divider_bottom"> <td>18 years</td> <td>50 years</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Abdominal ultrasound</td> <td>Every 6 months</td> <td>Birth</td> <td>18 years</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Urine steroids</td> <td>Every 6 months</td> <td>Birth</td> <td>18 years</td> <td>When abdominal ultrasound does not allow a proper imaging of the adrenal glands</td> </tr> <tr> <td>Colonoscopy<sup>¶</sup></td> <td>Every 5 years</td> <td>18 years</td> <td>Indefinite</td> <td>Only if the carrier received abdominal radiotherapy for the treatment of a previous cancer <strong>or</strong> if there is a familial history of colorectal tumors suggestive of an increased genetic risk</td> </tr> </tbody></table></div><div class="graphic_footnotes">MRI: magnetic resonance imaging.<br/>* A germline disease-causing <em>TP53</em> variant should be considered as "high risk" if the index case has developed a childhood cancer; <strong>or</strong> childhood cancers have been observed within the family; <strong>or</strong> this variant has already been detected in other families with childhood cancers; <strong>or </strong>this variant corresponds to a dominant-negative missense variant.<br/>¶ The first scan should be conducted with intravenous gadolinium enhancement; in children, brain MRI should alternate with the whole-body MRI, so that the brain is imaged at least every 6 months.</div><div class="graphic_reference">Adapted from: Frebourg T, Bajalica Lagercrantz S, Oliveira C, et al. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet 2020; 28:1379. Available at: <a href="https://www.nature.com/articles/s41431-020-0638-4" target="_blank">https://www.nature.com/articles/s41431-020-0638-4</a>. Copyright © 2020 The Authors. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License 4.0</a>.</div><div id="graphicVersion">Graphic 130818 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
